Rhythm Pharmaceuticals (RYTM) Stock Chart & Stock Price History $101.68 +2.98 (+3.02%) Closing price 08/21/2025 04:00 PM EasternExtended Trading$102.46 +0.78 (+0.77%) As of 05:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rhythm Pharmaceuticals Stock Price Performance The Rhythm Pharmaceuticals (RYTM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 130.10%, with a year-to-date return of 81.64%. In the past month, the stock has increased 15.78%, reflecting recent market activity. As of the latest close, Rhythm Pharmaceuticals traded at $101.68 with a market cap of $6.75 billion and volume of 682,917 shares. Five years ago, the stock traded at $18.47, representing a 450.51% increase over that period. At the time, it had a market cap of $818.40 million and a volume of 154,022 shares. Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.17%1 Month Performance+15.78%3 Month Performance+63.97%Year-To-Date Performance+81.64%1 Year Performance+130.10%5 Year Performance+450.51% RYTM Stock Chart for Friday, August, 22, 2025 RYTM Chart by TradingView Rhythm Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$98.70$101.68+3.02%$101.74$97.33682,917 shs$6.75 billion08/20/2025$97.19$98.70+1.55%$98.91$97.21462,154 shs$6.56 billion08/19/2025$98.09$97.19-0.92%$97.87$93.64349,469 shs$6.46 billion08/18/2025$97.61$98.09+0.49%$98.24$96.72404,946 shs$6.52 billion08/15/2025$96.48$97.61+1.17%$97.80$95.80522,257 shs$6.48 billion08/14/2025$97.86$96.48-1.41%$97.55$95.30583,771 shs$6.41 billion08/13/2025$96.46$97.86+1.45%$99.04$95.76733,610 shs$6.50 billion08/12/2025$94.31$96.46+2.28%$96.65$93.55538,693 shs$6.41 billion08/11/2025$91.98$94.31+2.53%$94.39$89.21626,069 shs$6.26 billion08/08/2025$92.48$91.98-0.54%$93.71$90.48819,638 shs$5.85 billion Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$90.01$92.48+2.74%$92.48$88.00557,282 shs$5.88 billion08/06/2025$88.57$90.01+1.63%$90.99$87.99639,224 shs$5.73 billion08/05/2025$90.24$88.57-1.85%$90.09$85.73674,592 shs$5.63 billion08/04/2025$88.30$90.24+2.20%$90.40$87.16624,935 shs$5.74 billion08/01/2025$85.23$88.30+3.60%$88.42$84.39666,964 shs$5.62 billion07/31/2025$84.66$85.23+0.67%$86.67$83.98472,989 shs$5.42 billion07/30/2025$85.63$84.66-1.13%$87.09$84.14517,776 shs$5.39 billion07/29/2025$85.68$85.63-0.06%$85.93$84.72418,777 shs$5.45 billion07/28/2025$86.45$85.68-0.89%$86.88$84.22653,752 shs$5.45 billion07/25/2025$87.27$86.45-0.94%$87.34$85.81402,780 shs$5.50 billion07/24/2025$87.81$87.27-0.61%$88.36$86.75388,632 shs$5.55 billion07/23/2025$87.82$87.81-0.01%$89.25$86.86532,583 shs$5.59 billion07/22/2025$88.63$87.82-0.91%$89.67$87.10551,578 shs$5.59 billion07/21/2025$89.20$88.63-0.64%$90.11$87.86667,966 shs$5.64 billion Related Companies Insmed Stock Chart Summit Therapeutics Stock Chart Teva Pharmaceutical Industries Stock Chart Genmab A/S Stock Chart Ascendis Pharma A/S Stock Chart Dr. Reddy's Laboratories Stock Chart Viatris Stock Chart QIAGEN Stock Chart Moderna Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RYTM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access